ESR1 and cancer: The underlying molecular mechanisms were examined by transcriptome analyzes, which revealed that the knockdown of ERβ in the ERα-negative cell line led to increased expression of several cancer-related genes, including cell cycle regulator CCNL1 and tumor-promoting NMPT, but to repression of genes associated with differentiation, apoptosis, or growth inhibition.